These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26864104)

  • 1. Discovery and bio-optimization of human antibody therapeutics using the XenoMouse® transgenic mouse platform.
    Foltz IN; Gunasekaran K; King CT
    Immunol Rev; 2016 Mar; 270(1):51-64. PubMed ID: 26864104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice.
    Jakobovits A; Amado RG; Yang X; Roskos L; Schwab G
    Nat Biotechnol; 2007 Oct; 25(10):1134-43. PubMed ID: 17921999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of transgenic mice for therapeutic antibody discovery.
    Lee EC; Owen M
    Methods Mol Biol; 2012; 901():137-48. PubMed ID: 22723098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibody Engineering: From the Idea to Its Implementation].
    Polanovsky OL
    Mol Biol (Mosk); 2017; 51(6):1039-1045. PubMed ID: 29271966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies.
    Green LL
    J Immunol Methods; 1999 Dec; 231(1-2):11-23. PubMed ID: 10648924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage display-derived human antibodies in clinical development and therapy.
    Frenzel A; Schirrmann T; Hust M
    MAbs; 2016 Oct; 8(7):1177-1194. PubMed ID: 27416017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human Antibodies.
    Chen WC; Murawsky CM
    Front Immunol; 2018; 9():460. PubMed ID: 29563917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-specific human monoclonal antibodies from transgenic mice.
    Mompó SM; González-Fernández A
    Methods Mol Biol; 2014; 1060():245-76. PubMed ID: 24037845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeutics.
    Kellermann SA; Green LL
    Curr Opin Biotechnol; 2002 Dec; 13(6):593-7. PubMed ID: 12482519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-awaited magic bullets: therapeutic human monoclonal antibodies from transgenic mice.
    Jakobovits A
    Expert Opin Investig Drugs; 1998 Apr; 7(4):607-14. PubMed ID: 15991997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monoclonal antibodies from transgenic mice.
    Lonberg N
    Handb Exp Pharmacol; 2008; 181(181):69-97. PubMed ID: 18071942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mouse strains as platforms for the successful discovery and development of human therapeutic monoclonal antibodies.
    Green LL
    Curr Drug Discov Technol; 2014 Mar; 11(1):74-84. PubMed ID: 23978036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal immunization merges with innovative technologies: A new paradigm shift in antibody discovery.
    Prabakaran P; Rao SP; Wendt M
    MAbs; 2021; 13(1):1924347. PubMed ID: 33947305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human antiglomerular basement membrane autoantibody disease in XenoMouse II.
    Meyers KE; Allen J; Gehret J; Jacobovits A; Gallo M; Neilson EG; Hopfer H; Kalluri R; Madaio MP
    Kidney Int; 2002 May; 61(5):1666-73. PubMed ID: 11967016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered antibodies accelerating drug discovery and development.
    Zhu Z
    IDrugs; 2001 Dec; 4(12):1346-8. PubMed ID: 15931562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and humanization of a functional bispecific EGFR × CD16 diabody using a refolding system.
    Asano R; Nakayama M; Kawaguchi H; Kubota T; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    FEBS J; 2012 Jan; 279(2):223-33. PubMed ID: 22074399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully human antibodies from transgenic mouse and phage display platforms.
    Lonberg N
    Curr Opin Immunol; 2008 Aug; 20(4):450-9. PubMed ID: 18606226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular engineering and design of therapeutic antibodies.
    Presta LG
    Curr Opin Immunol; 2008 Aug; 20(4):460-70. PubMed ID: 18656541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody humanization methods for development of therapeutic applications.
    Ahmadzadeh V; Farajnia S; Feizi MA; Nejad RA
    Monoclon Antib Immunodiagn Immunother; 2014 Apr; 33(2):67-73. PubMed ID: 24746146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.